Barclays raised the firm’s price target on Colgate-Palmolive to $96 from $91 and keeps an Equal Weight rating on the shares post the Q2 report. While organic sales beat elevated expectations, the stand-out figure this quarter was the 4.7% volume growth, particularly in a market that is prizing companies that can deliver any volume growth at all, the analyst tells investors in a research note. The firm believes Colgate’s Q2 results will prove best in class within staples.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive downgraded to Hold from Buy at HSBC
- CL Earnings: Colgate-Palmolive Reports Better-than-Expected Q2 Results
- Options Volatility and Implied Earnings Moves Today, July 26, 2024
- Colgate-Palmolive reports Q2 base profit margin up 300 bps to 60.8%
- Colgate-Palmolive backs FY24 net sales growth view of 2%-5%
